Polyclonal T‐cell antibody showed no clear difference in bronchiolitis obliterans syndrome compared with no antibody induction (moderate certainty).
Antibody (T cell) probably leads to lower failure of reversal of acute rejection compared with steroid (stratified by antibody type) (moderate certainty).
Antibody (T cell) showed no clear difference in recurrent rejection compared with steroid (stratified by antibody type) (moderate certainty).
Antibody (T cell) showed no clear difference in graft loss or death with a functioning graft compared with steroid (stratified by antibody type) (low certainty).
Antibody (T cell) showed no clear difference in graft loss censored for death compared with steroid (stratified by antibody type) (low certainty).
It is very uncertain whether antibody (T cell) changes death compared with steroid (stratified by antibody type) (very low certainty).
It is very uncertain whether antibody (T cell) changes treatment adverse events: fever, chill, or malaise after drug… compared with steroid (stratified by antibody type) (very low certainty).
T‐cell antibody induction showed no clear difference in mortality Mortality at latest compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in graft loss Graft loss (including death with a functioning graft) at… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in acute rejection Number of participants who experienced at least 1… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in infection Number of participants who experienced at least 1 episode… compared with corticosteroid induction (low certainty).
T‐cell antibody induction may leads to lower cytomegalovirus infection Number of participants who experienced at… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in hepatitis C recurrence Number of participants diagnosed with… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in malignancy Number of participants diagnosed with a malignancy compared with corticosteroid induction (low certainty).
T‐cell antibody induction may leads to lower diabetes mellitus Number of participants with new‐onset diabetes… compared with corticosteroid induction (low certainty).
T‐cell antibody induction may leads to lower mortality Mortality at latest compared with placebo/no intervention (low certainty).
T‐cell antibody induction may leads to lower graft loss including death Graft loss including death at latest compared with placebo/no intervention (low certainty).
T‐cell antibody induction probably leads to lower acute rejection Number of participants who experienced at least 1… compared with placebo/no intervention (moderate certainty).
Polyclonal T‐cell antibody induction showed no clear difference in mortality compared with interleukin‐2 receptor antagonist induction (moderate certainty).
Polyclonal T‐cell antibody induction showed no clear difference in acute rejection compared with interleukin‐2 receptor antagonist induction (moderate certainty).